Detection of chromosomal alterations in bladder cancer by comparative genomic hybridization

BJU International

Volumn 87, Issue 9, 2001, Pages 889-893

  Yu, D S ^a,b   Hsieh, D S ^a   Chang, S Y ^a  

^a NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^b TRI SERVICE GENERAL HOSPITAL   (Taiwan)

Author keywords

Chromosome aberrations; Comparative genomic hybridization; Transitional cell carcinoma

Indexed keywords

ARTICLE; BLADDER CARCINOMA; CANCER CELL CULTURE; CANCER GROWTH; CANCER STAGING; CHROMOSOME 1; CHROMOSOME 14; CHROMOSOME 16; CHROMOSOME 16Q; CHROMOSOME 1P; CHROMOSOME 21; CHROMOSOME 3P; CHROMOSOME 4P; CHROMOSOME 9; CHROMOSOME 9Q; CHROMOSOME ABERRATION; CHROMOSOME DELETION; CHROMOSOME LOSS; CHROMOSOME MUTATION; CHROMOSOME YP; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; HETEROZYGOTE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; Y CHROMOSOME;

CARCINOMA, TRANSITIONAL CELL; CHROMOSOME ABERRATIONS; HUMANS; NUCLEIC ACID HYBRIDIZATION; PROGNOSIS; TUMOR CELLS, CULTURED; URINARY BLADDER NEOPLASMS;

EID: 0035725871     PISSN: 14644096     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-410X.2001.02175.x     Document Type: Article

References (20)

1. Chemotherapy of urologic malignancies
2. Allelotype of human bladder cancer
3. Loss of chromosome 11 and 11 p/q imbalances in bladder cancer detected by fluorescence in situ hybridization
4. Chromosomal aberrations associated with invasion in papillary superficial bladder cancer
5. Gains and losses of DNA sequences in osteosarcomas by comparative genomic hybridization
6. Genetic aberrations detected by comparative genomic hybridization predict outcome in node-negative breast cancer
7. Comparative genomic hybridization for detection of DNA copy number abnormalities in renal cell carcinoma
8. Genetic alterations in untreated metastases and androgen-independent prostate cancer detected by comparative genomic hybridization and allelotyping
9. Accumulation of genetic changes is associated with poor prognosis in grade II astrocytomas
10. Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors
11. Identification of novel DNA amplifications and deletions in primary bladder cancer by comparative genomic hybridization
12. p53 nuclear protein accumulation correlates with mutations in the p53 gene, tumor grade, and stage in bladder cancer
13. Heterogeneity of erbB-2 gene amplification in bladder cancer
14. C-myc copy number gains in bladder cancer detected by fluorescence in situ hybridization
15. Marked genetic differences between stage pTa and stage pT1 papillary bladder cancer detected by comparative genomic hybridization
16. Chromosomal imbalances are associated with a high risk of progression in early invasive (pT1) urinary bladder cancer
17. Chromosomal imbalances in noninvasive papillary bladder neoplasms (pTa)
18. Detection of genetic alterations in bladder tumors by comparative genomic hybridization and cytogenetic analysis